| Name | Relative rentention time | Relative response factor | Acceptance Criteria for 2.5-, 5- and 10-mg Tablets, NMT (%) |
|---|---|---|---|
| Impurity A | 0.71 | - | - |
| Ramipril | 1 | - | - |
| Impurity B | 1.31 | - | - |
| Impurity C | 1.63 | - | - |
| Impurity D | 1.92 | 0.91 | 6.0 |
| Any unspecified degradation product | - | 1 | 0.2 |
| Total degradation product (not included impurity D) | - | - | 1.0 |